Multiple Osteolysis of Peripheral Extremities in a Patient with Adult T Cell Leukemia/Lymphoma

Internal Medicine

Volumn 38, Issue 10, 1999, Pages 820-823

  Matsushima, Takamitsu ^a   Yamamoto, Masahiro ^a   Sakai, Kouko ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

IL 6; Irradiation therapy; Osteoclast; Osteolysis; PTHrP

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; INTERLEUKIN 6;

AGED; ARTICLE; BLOOD; CASE REPORT; FEMALE; HUMAN; LIMB; MULTIMODALITY CANCER THERAPY; OSTEOLYSIS; RADIOGRAPHY; T CELL LYMPHOMA;

AGED; COMBINED MODALITY THERAPY; EXTREMITIES; FEMALE; HTLV-I ANTIBODIES; HUMANS; INTERLEUKIN-6; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; OSTEOLYSIS;

EID: 0033210831     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.820     Document Type: Article

References (15)

1. Roodman GD. Mechanisms of Bone Lesions in Multiple Myeloma and Lymphoma. Cancer 80 (Suppl 8): 1557-1563, 1997.
2. Eto S. Hypercalcemia in Malignancy. Jpn J Clin Pathol 42: 943-951, 1994 (Abstract in English).
3. Suva LJ, Winslow GA, Wettenhall RE, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893-896, 1987.
4. Shirakawa F, Yamashita U, Tanaka Y, et al. Production of hone resorbing activity corresponding to interleukin-1α by adult T-cell leukemia cells in humans. Cancer Res 48: 4284-4287, 1988.
5. Wano Y, Hottori T, Matsuoka H, et al. Interleukin-1 gene expression in adult T cell leukemia. J Clin Invest 80: 911-916, 1987.
6. Tschachler E, Robert-Guroff M, Gallo RC, Reitz MS Jr. Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. Blood 73: 194-201, 1989.
7. Ishibashi K, Ishitsuka K, Chuman Y, et al. Tumor Necrosis factor-β in the serum of adult T-cell leukemia with hypercalcemia. Blood 77: 2451-2455, 1991.
8. Niitsu Y, Urushizaki Y, Koshida Y, et al. Expression of TGF-beta gene in adult T cell leukemia. Blood 71: 263-266, 1988.
9. Walls J, Bundred N, Howell A. Hypercalcemia and Bone Resorption in Malignancy. Clin Orthop 312: 51-63, 1995.
10. Kishimoto T. The biology of interleukin-6. Blood 74: 1-10, 1989.
11. Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH. B cell stimulatory factor-2 is involved in the differentiation of cytoloxic# T lymphocytes. J Immunol 140: 508-512, 1988.
12. Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T. IL-6/BSF-2 functions as killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 141: 1543-1549, 1988.
13. Mori N, Shirakawa F, Shimizu H, et al. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: Evidence for the involvement of NF-κB. Blood 84: 2904-2911, 1994.
14. Maguer-Satta V, Gazzolo L, Dodon MD. Human immature thymocytes as target cells of the leukemogenic activity of human T-cell leukemia virus type I. Blood 86: 1444-1452, 1995.
15. Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332: 83-85, 1988.